BBC

This fund collects money from investors and uses it to purchase shares in multiple biotechnology companies that are conducting clinical trials to test new drugs and medical treatments. Investors buy shares of the ETF to get exposure to many biotech companies at once instead of picking individual stocks. The fund makes money by charging a small percentage fee based on the total value of all the investor money it manages.